Discover Me Raises £3.1M to Build the UK's Most Comprehensive Integrated Genetics and Health Dataset

Discover Me, a UK health data company, has raised £3.1 million to build integrated biodata resources that combine genetic data with population health information. The company is developing datasets that link individual-level genomic sequencing results with broader health, lifestyle, and clinical data from participants — creating the kind of large-scale, richly annotated biodata resources that enable researchers to understand how genetic variation interacts with environmental and behavioural factors to produce complex disease outcomes.

The scientific and commercial value of large integrated health datasets has become well established. Studies like the UK Biobank have demonstrated that linking genomic data to health records, lifestyle surveys, and biological measurements from tens of thousands of participants enables discoveries about the genetic architecture of common diseases that would be impossible from smaller, less richly annotated datasets. Pharmaceutical companies use such datasets to identify drug targets, stratify patient populations for clinical trials, and understand the genetic factors that predict drug response or adverse events. Academic researchers use them to generate hypotheses about disease mechanisms. Health systems use insights from population genomics to design more effective prevention and screening programmes.

The diversity of the participant population is a particularly important dimension. Most large-scale genomic datasets have historically over-represented participants of European ancestry, limiting the generalisability of findings and their applicability to the many genetic variants that differ in frequency across ancestral populations. Discover Me is building datasets that incorporate participants from across the demographic spectrum of the UK population, improving the relevance of discoveries for all patient populations and expanding the commercial utility of the resource for pharmaceutical partners seeking globally applicable insights.

The funding will be used to scale participant recruitment, develop the data integration and analysis infrastructure, and build commercial partnerships with pharmaceutical companies, academic medical centres, and health research organisations that need access to well-annotated, diverse biodata for their research programmes.

Sources

• Discover Me — company website